Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.

Also called NCT06964464

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06964464
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06964464. Randomized; no masking; primary purpose treatment. Start 2025-08-17 (actual); primary completion 2031-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
Acronym
CARVTOP-ICD
Condition
Sudden Cardiac Death
Condition
Ventricular Arrhythmia
Condition
Implantable Cardioverter Defibrillator (ICD)
Condition
Beta-blocker Therapy
Condition
Cardiomyopathy
Intervention (Drug)
Metoprolol Succinate
Intervention (Drug)
Carvedilol
Lead sponsor
University of Rochester (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)

Record details

Record id
cardio:ct-nct06964464
Content hash
ac4da2e09fe8e73bf9715690c3976697a3a1c50d7e9c0701ad8b8207d02eb14a